The Artemisinin Derivatives market was valued at USD 655 million in 2020 and expected to grow at a CAGR of 6.05% during the forecast period from 2021 to 2027 to reach around USD 1,080 million in 2027.
Artemisinin derivatives are a group of active pharmaceutical ingredients which are used in the treatment of malaria. Artemisinin and its derivatives effectively fight against malarial and parasitic worm (helminth) infections. They have been proven to be the most effective and potential drugs to kill the parasites and their life cycle. Artemisinin is typically derived from the plant Artemisia annua and sweet wormwood. The global Artemisinin Derivatives market report offers detailed market insights on Artemisinin Derivatives at the global, regional, and country levels.
The key regions covered in the report include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Major countries covered in the report are the U.S., Canada, Mexico, Brazil, Argentina, China, Japan, India, South Korea, Germany, UK, France, Italy, Spain, Russia, South Africa, Turkey, Israel, GCC countries, etc. The report provides the market size of Artemisinin Derivatives for historical periods, i.e., from 2015 to 2019, estimates for the current year, and forecasts for the period between 2021 to 2027. The market size of Artemisinin Derivatives is a further breakdown on regional and country levels.
Global Artemisinin Derivatives Market Share by Region, 2020
Based on its type, the global Artemisinin Derivatives market can be segmented into Dihydroartemisinin, Artemisunate, and Others. The Dihydroartemisinin segment has over 45% share of total revenue generated by Artemisinin Derivatives in 2020. Dihydroartemisinin is the active metabolite of all artemisinin compounds, including artemisinin, artesunate, artemether, etc. Each above segment and subsegment is then further bifurcated at the global, regional, and country levels. Finally, the market size for each segment and subsegment is given in terms of volume and value (USD Million) for historical, present and forecast years.
Global Artemisinin Derivatives Market by Application Insights
Based on its application, the global Artemisinin Derivatives market can be segmented into Malaria Treatment, Scientific Research, and Others. The Malaria Treatment segment dominated the global Artemisinin Derivatives demand in 2020 with over 60% share in total revenue generated by this industry. Each above segment and subsegment is then further bifurcated at global, regional, and country levels. Finally, the market size for each segment and subsegment is given in terms of volume and value (USD Million) for historical, present and forecast years.
Global Artemisinin Derivatives Market Share by Application, 2020
Apart from quantitative analysis, the global Artemisinin Derivatives market report offers key trends in the industry. The report covers all key market driving forecasts, restraints, and opportunities for future growth in this industry. The report helps its readers to identify the key growth pockets in the global Artemisinin Derivatives industry through market attractiveness analysis offered for each segment in this industry. Moreover, a detailed analysis of the Artemisinin Derivatives industry using porter's five forces analysis helps the buyers of this report to have a bird's eye view of various aspects of this industry. It details the bargaining power of buyers as well as suppliers, the situation of competitive rivalry, the threat of substitutes, and entry barriers for new entrants.
The global Artemisinin Derivatives market report also covers import and export analysis on a regional level. The global Artemisinin Derivatives market includes the most updated insights, including COVID 19 impact analysis. In addition, the report covers a comparative analysis of the global Artemisinin Derivatives market on the basis of pre and post-COVID 19 scenarios.
Apart from this, the report covers a dedicated section for the analysis of competition in the global Artemisinin Derivatives industry. The report offers detailed company market share analysis on a global level which helps to understand the competitive scenario in the Artemisinin Derivatives industry. In addition, a detailed company profile section offers detailed insights about leading players in the Artemisinin Derivatives market. The company profile of each leading player includes a company overview, detailed product portfolio, and financial details such as sales volume, revenue, gross margin, etc. for Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource, Botanical Extracts EPZ Ltd and others.
Global Artemisinin Derivatives Market, Company Share 2020
The global Artemisinin Derivatives market report also offers insights into manufacturing cost analysis. This section focused on the analysis of raw material cost, key suppliers of raw materials, labor cost, market concentration of raw materials, manufacturing cost proportion of Artemisinin Derivatives, etc. This report highlights the manufacturing expenses and the manufacturing process of Artemisinin Derivatives. In addition, the repot also helps to understand the marketing channels used by most Artemisinin Derivatives industry players.
Historical & Forecast Period
2015 to 2020 – Historical Years
2021 – Current Year
2021 - 2027 – Forecast Period
This study report represents analysis for each segment from 2015 to 2027, considering 2019 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2020 to 2027.
Market Segmentation
Global Artemisinin Derivatives Market by Type, 2015 - 2027
Dihydroartemisinin
Artesunate
Others
Global Artemisinin Derivatives Market by Application, 2015 - 2027
Malaria Treatment
Scientific Research
Others
Global Artemisinin Derivatives Market by Region, 2015 - 2027
North America
Europe
Asia Pacific
Latin America
The Middle East and Africa
Global Artemisinin Derivatives Market: Key Players
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novant Bioresource
Botanical Extracts EPZ Ltd
Others
The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better understanding of the overall Artemisinin Derivatives market. In addition, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolio, and business strengths.
Frequently Asked Question:
The market for Artemisinin Derivatives is expected to reach USD 1,080 million Bn in 2028.
The Artemisinin Derivatives market is expected to see significant CAGR growth over the coming years, at 6.05%.
The report is forcasted from 2021 – 2027
The base year of this report is 2021.
Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource, Botanical Extracts EPZ Ltd, Company 10, Company 11, Company 12, Company 13 are some of the major players in the global market.
